Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

MDPV: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
← Older editNewer edit →
>Oskykins
Do not remove proofread and approval tags please.
>Tigereye440
No edit summary
Line 5: Line 5:
| {{proofread}}
| {{proofread}}
| {{Approval}}
| {{Approval}}
|}</center>
|}</center>Methylenedioxypyrovalerone (MDPV) is a psychoactive recreational drug with stimulant properties which acts as a norepinephrine-dopamine reuptake inhibitor (NDRI). It was first developed in the 1960s by a team at Boehringer Ingelheim. MDPV remained an obscure stimulant until around 2004 when it was reportedly sold as a designer drug. Products labeled as bath salts containing MDPV were previously sold as recreational drugs in gas stations and convenience stores in the United States, similar to the marketing for Spice and K2 as incense.
{{SubstanceBox
 
    <!-- Table Properties -->
    |MaterialTable_MaxWidth=auto
    |MaterialTable_Title={{PAGENAME}}
 
    <!-- Modules -->
    |ModuleSource=https://en.wikipedia.org/wiki/Methylenedioxypyrovalerone#/media/File:MDPV_3d.gif
    |ModuleCombination=false
    |ModuleStructure=https://en.wikipedia.org/wiki/Methylenedioxypyrovalerone#/media/File:MDPV_3d.gif
    |ModuleNomenclature=true
    |ModuleROA=true
 
    <!-- Source -->
    |PhotoImageFile= https://en.wikipedia.org/wiki/Methylenedioxypyrovalerone#/media/File:MDPV.svg
    |PhotoImageWidth= auto
    |PhotoImageCaption=
 
    <!-- Combination -->
    |CombinationImage1_Caption=
    |CombinationImage1_File=C:\Users\Brad Verret\Desktop\MDPV.jpg
    |CombinationImage1_Width=
 
    |MolecularStructureCaption=
    |SkeletalImageFile=https://upload.wikimedia.org/wikipedia/commons/7/7c/MDPV.svg
    |SkeletalImageWidth=
    |3DImageFile=https://en.wikipedia.org/wiki/Methylenedioxypyrovalerone#/media/File:MDPV_3d.gif
    |3DImageWidth=
 
    500
    |NameCommon= 3,4-Methylenedioxypyrovalerone
    |NameSubstitution= MDPV
    |NameSystematic= (RS)-1-(Benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one
 
    <!-- Dosage/Duration -->
 
    |SmokedROA=true
    |SmokedROA_Collapsed=true
    |SmokedROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity.
    |SmokedROA_Bioavailability= n/a
    |SmokedROA_Threshold=< 1 mg
    |SmokedROA_Light=1 - 2 mg
    |SmokedROA_Common=2 - 5 mg
    |SmokedROA_Strong=5 - 10 mg
    |SmokedROA_Heavy=> 10  mg
    |SmokedROA_TimelineFile=
    |SmokedROA_TimelineWidth=
    |SmokedROA_Duration= 4 - 6 hours
    |SmokedROA_Onset=10 seconds
    |SmokedROA_Peak=1 minute
    |SmokedROA_Offset= 3 hours
    |SmokedROA_Afterglow=6 hours
 
    |OralROA=true
    |OralROA_Collapsed=true
    |OralROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity.
    |OralROA_Bioavailability=n/a
    |OralROA_Threshold=< 1 mg
    |OralROA_Light=1 - 2 mg
    |OralROA_Common=2 - 5 mg
    |OralROA_Strong=5 - 1 mg
    |OralROA_Heavy= > 10 mg
    |OralROA_TimelineFile=
    |OralROA_TimelineWidth=
    |OralROA_Duration=8 - 12 hours
    |OralROA_Onset=30 minutes
    |OralROA_Peak=2 hours
    |OralROA_Offset=10 hours
    |OralROA_Afterglow=24 hours
 
|InsufflatedROA = true|InsufflatedROA_Afterglow = 12 hours|InsufflatedROA_Bioavailability = n/a|InsufflatedROA_Caption = '''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity.|InsufflatedROA_Collapsed = true|InsufflatedROA_Common = 2 - 5 mg|InsufflatedROA_Duration = 5 - 12 hours|InsufflatedROA_Heavy = 5 - 10 mg|InsufflatedROA_Light = 1 - 2 mg|InsufflatedROA_Offset = 5 hours|InsufflatedROA_Onset = 1 min|InsufflatedROA_Peak = 10 min|InsufflatedROA_Strong = 5 - 10 mg|InsufflatedROA_Threshold = < 1 mg}}
 
Methylenedioxypyrovalerone (MDPV) is a psychoactive recreational drug with stimulant properties which acts as a norepinephrine-dopamine reuptake inhibitor (NDRI). It was first developed in the 1960s by a team at Boehringer Ingelheim. MDPV remained an obscure stimulant until around 2004 when it was reportedly sold as a designer drug. Products labeled as bath salts containing MDPV were previously sold as recreational drugs in gas stations and convenience stores in the United States, similar to the marketing for Spice and K2 as incense.


Incidents of psychological and physical harm have been attributed to MDPV use.
Incidents of psychological and physical harm have been attributed to MDPV use.

Revision as of 00:37, 17 August 2015

Template:Proofread

This page has not been fully approved by the PsychonautWiki administrators.

It may contain incorrect information, particularly with respect to dosage, duration, subjective effects, toxicity and other risks. It may also not meet PW style and grammar standards.

Methylenedioxypyrovalerone (MDPV) is a psychoactive recreational drug with stimulant properties which acts as a norepinephrine-dopamine reuptake inhibitor (NDRI). It was first developed in the 1960s by a team at Boehringer Ingelheim. MDPV remained an obscure stimulant until around 2004 when it was reportedly sold as a designer drug. Products labeled as bath salts containing MDPV were previously sold as recreational drugs in gas stations and convenience stores in the United States, similar to the marketing for Spice and K2 as incense.

Incidents of psychological and physical harm have been attributed to MDPV use.

Retrieved from "http://psy.st/w/index.php?title=MDPV&oldid=42372"